| Title |
Human recombinant activated factor VII for upper gastrointestinal bleeding in patients with liver diseases
|
|---|---|
| Published in |
Cochrane database of systematic reviews, March 2012
|
| DOI | 10.1002/14651858.cd004887.pub3 |
| Pubmed ID | |
| Authors |
Arturo J Martí‐Carvajal, Despoina‐Elvira Karakitsiou, Georgia Salanti |
| Abstract |
Mortality from upper gastrointestinal bleeding in patients with liver disease is high. Recombinant human activated factor VII (rHuFVIIa) has been suggested for patients with liver disease and upper gastrointestinal bleeding. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Colombia | 2 | 67% |
| Unknown | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 67% |
| Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 95 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 1% |
| Brazil | 1 | 1% |
| Unknown | 93 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 13 | 14% |
| Student > Master | 12 | 13% |
| Other | 9 | 9% |
| Student > Ph. D. Student | 8 | 8% |
| Student > Bachelor | 7 | 7% |
| Other | 17 | 18% |
| Unknown | 29 | 31% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 40 | 42% |
| Nursing and Health Professions | 7 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 3% |
| Psychology | 3 | 3% |
| Social Sciences | 3 | 3% |
| Other | 3 | 3% |
| Unknown | 36 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 November 2020.
All research outputs
#6,360,165
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#7,655
of 11,499 outputs
Outputs of similar age
#40,178
of 169,202 outputs
Outputs of similar age from Cochrane database of systematic reviews
#106
of 177 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 33rd percentile – i.e., 33% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 169,202 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 177 others from the same source and published within six weeks on either side of this one. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.